Steve Schonfeld Schonfeld Strategic Advisors
Steve Schonfeld is the founder of Schonfeld Strategic Advisors, a multi-manager investment firm with roots in proprietary trading. Schonfeld allocates capital across quantitative and discretionary strategies with an emphasis on risk controls and diversification of return streams. The firm is a major name in the multi-strategy hedge fund landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.67B |
| 2 |
Amazon
AMZN
|
+$109M |
| 3 |
Verizon
VZ
|
+$64.3M |
| 4 |
Mastercard
MA
|
+$58M |
| 5 |
Micron Technology
MU
|
+$54M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Union Pacific
UNP
|
+$115M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$94.5M |
| 3 |
American Tower
AMT
|
+$69.6M |
| 4 |
Walmart Inc
WMT
|
+$67.4M |
| 5 |
American Express
AXP
|
+$63.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 11.79% |
| 2 | Technology | 9.94% |
| 3 | Financials | 9.21% |
| 4 | Consumer Discretionary | 9.11% |
| 5 | Healthcare | 6.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Global E Online
GLBE
$6.7B
| $3.97M | 0.03% |
+100,300
| New | +$3.61M |
|
577
Kiniksa Pharmaceuticals
KNSA
$6.19B
| $3.97M | 0.03% |
226,451
+17,951
| +9% | +$295K |
|
|
PXD
578
DELISTED
Pioneer Natural Resource Co.
PXD
| $3.97M | 0.03% |
17,662
+10,862
| +160% | +$2.55M |
|
|
LTHM
579
DELISTED
Livent Corporation
LTHM
| $3.97M | 0.03% |
+220,753
| New | +$3.44M |
|
580
Travelers Companies
TRV
$77.3B
| $3.97M | 0.03% |
20,820
-134,108
| -87% | -$23.2M |
|
|
SILK
581
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $3.96M | 0.03% |
322,584
+156,165
| +94% | +$1.46M |
|
582
GitLab
GTLB
$7.1B
| $3.93M | 0.03% |
62,444
+46,644
| +295% | +$2.36M |
|
583
Under Armour Class C
UA
$2.25B
| $3.92M | 0.03% |
+468,940
| New | +$3.39M |
|
584
Capri Holdings
CPRI
$1.55B
| $3.91M | 0.03% |
77,887
-196,205
| -72% | -$9.79M |
|
585
Viridian Therapeutics
VRDN
$2.72B
| $3.9M | 0.03% |
178,919
+70,882
| +66% | +$1.12M |
|
586
Clarivate
CLVT
$1.36B
| $3.86M | 0.03% |
+416,698
| New | +$3.08M |
|
587
Camden Property Trust
CPT
$11B
| $3.85M | 0.03% |
38,802
+24,001
| +162% | +$2.22M |
|
588
Lyft
LYFT
$6.69B
| $3.84M | 0.03% |
256,273
+140,173
| +121% | +$1.63M |
|
589
Conagra Brands
CAG
$8B
| $3.81M | 0.03% |
132,994
-23,955
| -15% | -$671K |
|
590
MGIC Investment
MTG
$6.38B
| $3.8M | 0.03% |
196,960
+131,372
| +200% | +$2.33M |
|
591
Keros Therapeutics
KROS
$214M
| $3.79M | 0.03% |
95,338
+17,538
| +23% | +$550K |
|
592
Public Storage
PSA
$60.7B
| $3.78M | 0.03% |
12,400
+7,100
| +134% | +$1.88M |
|
|
AMAM
593
DELISTED
Ambrx Biopharma Inc
AMAM
| $3.76M | 0.02% |
+263,743
| New | +$3M |
|
594
CALL
Tesla
TSLA
$1.38T
| $3.73M | 0.02% |
15,000
+5,000
| +50% | +$1.19M |
|
|
595
PUT
Tesla
TSLA
$1.38T
| $3.73M | 0.02% |
15,000
+5,000
| +50% | +$1.19M |
|
596
Leidos
LDOS
$17.4B
| $3.72M | 0.02% |
34,400
-250,008
| -88% | -$25.5M |
|
|
MRO
597
DELISTED
Marathon Oil Corporation
MRO
| $3.72M | 0.02% |
154,091
+110,205
| +251% | +$2.84M |
|
598
MannKind Corp
MNKD
$1.31B
| $3.69M | 0.02% |
1,014,888
+41,688
| +4% | +$159K |
|
599
State Street Energy Select Sector SPDR ETF
XLE
$41.5B
| $3.69M | 0.02% |
88,082
+88,080
| +4,404,000% | +$3.77M |
|
600
Dyne Therapeutics
DYN
$4.85B
| $3.67M | 0.02% |
+275,699
| New | +$2.69M |
|
Similar funds
Steve Schonfeld's Q4 2023 Portfolio in Review
As of Q4 2023, Steve Schonfeld held 2,384 positions worth $15.1B, up 17% from $12.9B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Steve Schonfeld deployed $548M of net new capital in Q4 2023, opening 671 new positions and adding to 477 existing holdings. Its largest new stake was Equifax: 214,316 shares worth $53M.
By sector, the portfolio is most concentrated in Industrials at 12% of assets, down from 16% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Union Pacific, an estimated $115M trimmed.
- Steve Schonfeld's largest Q4 2023 buy was Equifax: 214,316 shares worth $53M.
- Steve Schonfeld added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $1.67B increase.
- Steve Schonfeld's biggest Q4 2023 reduction was Union Pacific, cutting an estimated $115M.
- Steve Schonfeld fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q4 2023, selling an estimated $94.5M.
- Steve Schonfeld's ten largest holdings make up 29% of its $15.1B portfolio in Q4 2023.
- Steve Schonfeld opened 671 new positions and closed 562 in Q4 2023.
- Steve Schonfeld's portfolio value rose 17% quarter-over-quarter to $15.1B.
Based on Schonfeld Strategic Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.